Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s stock price was up 9.9% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as $2.13 and last traded at $2.00, approximately 1,661,600 shares changed hands during mid-day trading. An increase of 482% from the average daily volume of 285,576 shares. The stock had previously closed at $1.82.
Specifically, insider Andreas Busch bought 125,000 shares of the stock in a transaction dated Friday, November 15th. The shares were acquired at an average cost of $1.82 per share, for a total transaction of $227,500.00. Following the completion of the transaction, the insider now owns 125,000 shares in the company, valued at approximately $227,500. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
The firm’s 50-day moving average is $6.61 and its 200 day moving average is $10.42. The company has a debt-to-equity ratio of 0.60, a current ratio of 6.32 and a quick ratio of 6.32.
About Cyclerion Therapeutics (NASDAQ:CYCN)
There is no company description available for Cyclerion Therapeutics Inc
Further Reading: Are FAANG stocks a good investment?
Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.